Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | D-methylphenidate (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 💬
|
| 2 | Methylphenidate (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [7] 6 6, 13, 34, 84, 113, 179, 206 💬
|
| 3 | Methylphenidate (MPD) (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 6 6 💬
|
| 4 | Methylphenidate (overencapsulated) (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 💬
|
| 5 | Methylphenidate 10mg tablets (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 💬
|
| 6 | METHYLPHENIDATE HYDROCHLORIDE | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [2] 6 6, 13 💬
|
| 7 | Methylphenidate modified release (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 8 | Methylphenidate modified release 20 mg (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 9 | Methylphenidate modified release 30 mg (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 10 | Methylphenidate modified release 40 mg (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 💬
|
| 11 | Methylphenidate Oral Solution (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Methylphenidate hydrochloride) | [2] Methylphenidate hydrochloride
Methylphenidate hydrochloride
(Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),Methylphenidate 💬 | [2] SLC6A2 SLC6A2,SLC6A3 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 206 206 💬
|
| 12 | Methylphenidate, fluoxetin, risperidone (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [2] Methylphenidate Methylphenidate (Methylphenidate hydrochloride),Risperidone | [3] Risperidone
Risperidone
,Methylphenidate hydrochloride (Methylphenidate hydrochloride, METHYLPHENIDATE HYDROCHLORIDE CD, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE), Methylphenidate 💬 | [4] DRD2 DRD2,HTR2A, SLC6A2, SLC6A3 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬 | [2] 179 179, 206 💬
|
